Hypernephroma Archive - Seite 2 von 6 - IOZK

Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway

2015-05-01/in Hypernephroma, International Publications, Newcastle Disease Virus

Matched-pair analysis of dendritic cell versus targeted-therapy in patients with metastatic renal cell carcinoma

2015-03-01/in Dendritic Cells, Hypernephroma, International Publications

Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response

2014-09-23/in Dendritic Cells, Hypernephroma, International Publications, Malignant Melanoma

Improved vaccine efficacy of tumor exosome compared to tumor lysate loaded dendritic cells in mice

2014-08-05/in Dendritic Cells, Exosome, Glioblastoma, Hypernephroma, International Publications

A phase I, open label, dose escalation and cohort expansion study to evaluate the safety and immune response to autologous dendritic cells (DC) transduced with AdGMCA9 (DC-AdGMCAIX) in patients with mRCC.

2014-07-31/in Dendritic Cells, Hypernephroma, International Publications

Intratumoral vaccination with activated allogeneic dendritic cells in patients with newly diganosed metastatic renal cell carcinoma (mRCC).

2014-06-01/in Dendritic Cells, Hypernephroma, International Publications

Survival in metastatic Ewing sarcoma (EWS) and rhabdomyosarcoma (RMS) following consolidation immunotherapy with autologous lymphocyte infusion, dendritic cell vaccines ± CYT107 (rhIL-7).

2013-06-03/in Dendritic Cells, Hypernephroma, International Publications, Soft Tissue Sarcoma

The oncolytic activity of Newcastle disease virus in clear cell renal carcinoma cells in normoxic and hypoxic conditions: the interplay between von Hippel-Lindau and interferon-β signaling

2013-03-18/in Hypernephroma, International Publications, Newcastle Disease Virus

Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer: a clinical phase I/II study

2013-03-04/in Dendritic Cells, Hypernephroma, International Publications

Allogeneic partially HLA-matched dendritic cells (DC) as a vaccine in metastatic renal cell cancer (mRCC): Final analysis of a clinical phase I/II study.

2012-06-01/in Dendritic Cells, Hypernephroma, International Publications